News

At Clinical Endpoints, we are a Site Management Organization (SMO) that is dedicated to revolutionizing neurology research to enhance the lives of individuals with neurological disorders. Our focus spans various conditions, including Alzheimer’s and Parkinson’s disease, as we seek innovative…   Read More

Imaging is essential in hepatocellular carcinoma (HCC) clinical trials, guiding diagnosis and monitoring treatment efficacy. Among the most valuable tools are triphasic CT and/or MRI, which significantly improve diagnostic accuracy by differentiating liver tumors from surrounding tissues and assessing treatment…   Read More

Medical imaging is integral to the evolution of breast cancer clinical trials providing crucial insights into tumor detection and treatment evaluation. Mammography and ultrasound are the standard imaging modalities for screening and initial diagnosis, MRI helps determine the extent of…   Read More

Prostate cancer is the most common cancer among men and the second leading cause of cancer death after lung cancer. Advances in imaging techniques, particularly multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT (that Imaging Endpoints helped…   Read More

Lymphoma treatment is undergoing a remarkable transformation through the integration of advanced imaging biomarkers. Updated CT and PET response criteria are improving assessment strategies, while other functional imaging methods offer new insights into treatment efficacy. Amidst these technological advancements, bone…   Read More

Imaging plays a crucial role in the diagnosis and management of lung cancer, which remains a leading cause of cancer-related deaths worldwide. Radiological methods like CT (including low-dose) and PET, have become essential for early detection, staging, and ongoing monitoring…   Read More

Glioblastoma multiforme (GBM) is the most malignant and prevalent subtype of glioma, representing the most common primary brain tumor in adults. MRI is considered the gold standard for assessing glioblastoma. However, structural MRI alone is insufficient for accurately interpreting treatment-related…   Read More

Gastrointestinal Stromal Tumors (GIST) pose unique challenges in clinical settings due to their distinct molecular features and behaviors. Imaging plays a pivotal role in evaluating diagnosis and treatment agents in GIST clinical trials. Various imaging techniques are utilized for monitoring…   Read More

Sarcomas and bone tumors pose a distinctive challenge in oncology imaging, necessitating standardized protocols for precise tumor response determination in clinical trials. Multiple imaging techniques are needed to address the heterogeneity of these tumors.  Imaging Endpoints applies the leading and…   Read More

Hematologic cancers, originating from lymphoid and myeloid cell lines, represent about 10% of newly diagnosed malignant tumors in the United States. Among these, Multiple Myeloma survival has improved over the last decade, with the emergence of cutting-edge therapies like CAR…   Read More